Efficacy and safety of full oral vinorelbine (NVBO) on D1 and D8 with carboplatin (CBDCA) as first line treatment in advenced non-small lung cancer (NSCLC) patients: Results of prospective study in nonrandomized population of 259 patients

• Authors: SKŘIČKOVÁ Jana; KADLEC Bohdan; VENCLÍČEK Ondřej; JANÁSKOVÁ Tereza; KOLEK Vítězslav; GRYGÁRKOVÁ Ivona; ČOUPKOVÁ Helena; REITERER Pavel
• Year of publication: 2013
• Type: Conference abstract
• MU Faculty or unit: Faculty of Medicine
• Description: Background: The purpose was to evaluate the activity and feasibility of CBDCA together with NVBO in 1st line treatment NSCLC patients. Conclusions: The treatment with NVBO and CBDCA was well tolerated with evidence of high antitumour activity. This combination was active in all groups patients according histology.